Clinical trials
Completed Glucose Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
226 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 11 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 10 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 10 |
| 2014 | 13 |
| 2015 | 10 |
| 2016 | 16 |
| 2017 | 19 |
| 2018 | 18 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 15 |
| 2024 | 8 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 226 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 33 |
| Eli Lilly and Company | 8 |
| University Hospital, Gentofte, Copenhagen | 8 |
| AstraZeneca | 5 |
| Maastricht University Medical Center | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Pfizer | 5 |
| University of Aarhus | 5 |
| Steno Diabetes Center Copenhagen | 4 |
| Ultragenyx Pharmaceutical Inc | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 226 |
| Diabetes Mellitus | 106 |
| Diabetes Mellitus, Type 2 | 84 |
| Metabolic Diseases | 76 |
| Endocrine System Diseases | 61 |
| Dyslipidemias | 37 |
| Insulin Resistance | 32 |
| Diabetes Mellitus, Type 1 | 25 |
| Diabetes Mellitus, Lipoatrophic | 19 |
| Autoimmune Diseases | 15 |
Trials
Showing 1 to 25 of 226. Each trial links to its page on Pharma Observatory.
126 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.